Canine and Feline Insulinoma

Floryne O. Buishand*, Jolle Kirpensteijn

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract / Description of output

This chapter mainly focuses on canine insulinoma. Insulinoma is the most common pancreatic endocrine tumor in the dog. Clinical signs of canine insulinoma often occur intermittently. In the initial stages hypoglycemic episodes are preceded by fasting, exercise, excitement or stress, because those situations lead to increased glucose utilization. Insulinoma therapy can be divided into medical management and surgical treatment. Surgery is considered the treatment of choice because it has been associated with the longest survival times; however, most dogs are also treated with medical management at some point in the disease course. Canine insulinoma has a guarded prognosis because metastasis, tumor regrowth, and return of clinical signs are almost inevitable. The prognosis for dogs treated with surgery combined with medical treatment is significantly better than the prognosis for dogs receiving medical treatment alone.

Original languageEnglish
Title of host publicationSmall Animal Soft Tissue Surgery
PublisherWiley Blackwell
Pages32-42
Number of pages11
ISBN (Electronic)9781118997505
ISBN (Print)9780813807829
DOIs
Publication statusPublished - 4 Jan 2013

Keywords / Materials (for Non-textual outputs)

  • Canine insulinoma
  • Dogs
  • Feline insulinoma
  • Medical management
  • Prognosis
  • Surgical treatment

Fingerprint

Dive into the research topics of 'Canine and Feline Insulinoma'. Together they form a unique fingerprint.

Cite this